WESTFIELD CAPITAL MANAGEMENT CO LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$85,934,978
+18.3%
4,193,996
+14.7%
0.58%
+26.6%
Q2 2023$72,640,488
+31.0%
3,655,787
+13.0%
0.46%
+17.9%
Q1 2023$55,431,104
-2.5%
3,235,908
+11.4%
0.39%
-10.7%
Q4 2022$56,861,711
+34.3%
2,905,555
+9.5%
0.44%
+30.7%
Q3 2022$42,345,000
-8.2%
2,653,202
-20.9%
0.34%
-7.4%
Q2 2022$46,143,000
+32.6%
3,353,393
+52.9%
0.36%
+62.8%
Q1 2022$34,792,000
-21.8%
2,193,725
+7.6%
0.22%
-15.5%
Q4 2021$44,489,000
-26.6%
2,037,991
+0.6%
0.26%
-27.7%
Q3 2021$60,572,000
-34.2%
2,026,481
-2.4%
0.36%
-33.8%
Q2 2021$91,995,000
+24.6%
2,077,095
+24.9%
0.55%
+20.0%
Q1 2021$73,816,000
-15.6%
1,663,652
+4.3%
0.46%
-11.6%
Q4 2020$87,469,000
+155.3%
1,594,981
+6.4%
0.52%
+133.8%
Q3 2020$34,256,000
-4.4%
1,498,493
-12.4%
0.22%
-9.8%
Q2 2020$35,822,000
+52.7%
1,711,501
+1.8%
0.25%
+18.8%
Q1 2020$23,456,000
+29.2%
1,681,434
+110.8%
0.21%
+60.5%
Q4 2019$18,153,000
+98.2%
797,596
+1.5%
0.13%
+76.7%
Q3 2019$9,158,000
+8.2%
786,114
+39.3%
0.07%
+14.1%
Q2 2019$8,462,000
+2205.7%
564,132
+3686.1%
0.06%
+2033.3%
Q3 2018$367,00014,9000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders